322 related articles for article (PubMed ID: 12914736)
21. Primary Aldosteronism.
Quencer KB; Rugge JB; Senashova O
Am Fam Physician; 2023 Sep; 108(3):273-277. PubMed ID: 37725461
[TBL] [Abstract][Full Text] [Related]
22. [Idiopathic primary hyperaldosteronism: significance of functional diagnosis].
Bianda T; Schmid C
Schweiz Med Wochenschr; 1998 Aug; 128(35):1277-83. PubMed ID: 9782547
[TBL] [Abstract][Full Text] [Related]
23. Primary aldosteronism: from bench to bedside.
Sukor N
Endocrine; 2012 Feb; 41(1):31-9. PubMed ID: 22042487
[TBL] [Abstract][Full Text] [Related]
24. Treatment of primary hyperaldosteronism.
Araujo-Castro M
Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
[TBL] [Abstract][Full Text] [Related]
25. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
[TBL] [Abstract][Full Text] [Related]
26. Management of primary aldosteronism: its complications and their outcomes after treatment.
Giacchetti G; Turchi F; Boscaro M; Ronconi V
Curr Vasc Pharmacol; 2009 Apr; 7(2):244-49. PubMed ID: 19356005
[TBL] [Abstract][Full Text] [Related]
27. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
[TBL] [Abstract][Full Text] [Related]
28. [Hyperaldosteronism].
Scholl UI
Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
[TBL] [Abstract][Full Text] [Related]
29. Primary aldosteronism.
McGuffin WL; Gunnells JC
Urol Clin North Am; 1977 Jun; 4(2):227-37. PubMed ID: 331615
[No Abstract] [Full Text] [Related]
30. [Primary hyperaldosteronism and adrenal tumors. Clinico-surgical experience with 9 patients].
Bortolotto LA; Silva HB; Lopes HF; Jatene F; Jatene A; Pileggi F
Arq Bras Cardiol; 1994 Mar; 62(3):165-9. PubMed ID: 7980077
[TBL] [Abstract][Full Text] [Related]
31. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
32. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
33. Aldosterone antagonism: an emerging strategy for effective blood pressure lowering.
Pratt-Ubunama MN; Nishizaka MK; Calhoun DA
Curr Hypertens Rep; 2005 Jun; 7(3):186-92. PubMed ID: 15913492
[TBL] [Abstract][Full Text] [Related]
34. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
Berge C; Courand PY; Harbaoui B; Paget V; Khettab F; Bricca G; Fauvel JP; Lantelme P
J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
[TBL] [Abstract][Full Text] [Related]
35. Primary aldosteronism: diagnosis and treatment.
Pimenta E; Calhoun DA
J Clin Hypertens (Greenwich); 2006 Dec; 8(12):887-93. PubMed ID: 17170615
[TBL] [Abstract][Full Text] [Related]
36. Diurnal blood pressure pattern in patients with primary aldosteronism.
Zacharieva S; Orbetzova M; Elenkova A; Stoynev A; Yaneva M; Schigarminova R; Kalinov K; Nachev E
J Endocrinol Invest; 2006 Jan; 29(1):26-31. PubMed ID: 16553030
[TBL] [Abstract][Full Text] [Related]
37. [Primary aldosteronism].
Krysiak R; Okopień B; Herman ZS
Przegl Lek; 2007; 64(1):31-6. PubMed ID: 18183829
[TBL] [Abstract][Full Text] [Related]
38. Aldosteronism in hypertension. The spironolactone response test.
Spark RF; Melby JC
Ann Intern Med; 1968 Oct; 69(4):685-91. PubMed ID: 5682243
[No Abstract] [Full Text] [Related]
39. Diagnosis and treatment of primary aldosteronism.
Reincke M; Bancos I; Mulatero P; Scholl UI; Stowasser M; Williams TA
Lancet Diabetes Endocrinol; 2021 Dec; 9(12):876-892. PubMed ID: 34798068
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and therapy of primary aldosteronism: new aspects].
Asbach E; Reincke M
Dtsch Med Wochenschr; 2022 Jan; 147(3):92-97. PubMed ID: 35100641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
